Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.19 USD -3.25% Market Closed
Market Cap: 5.3m USD

Wall Street
Price Targets

IDXG Price Targets Summary
Interpace Biosciences Inc

There are no price targets for IDXG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Interpace Biosciences Inc Competitors:
Price Targets
1951
Jinxin Fertility Group Ltd
44% Upside
AHX
Apiam Animal Health Ltd
3% Upside
IDHC
Integrated Diagnostics Holdings PLC
16% Upside
QC7
Q & M Dental Group (Singapore) Ltd
9% Downside
FLGT
Fulgent Genetics Inc
34% Upside
MD
MEDNAX Inc
9% Upside
EUDA
EUDA Health Holdings Ltd
149% Upside
LFST
Lifestance Health Group Inc
26% Upside

Revenue
Forecast

Revenue Estimate
Interpace Biosciences Inc

For the last 13 years the compound annual growth rate for Interpace Biosciences Inc's revenue is -9%. The projected CAGR for the next 3 years is -1%.

-9%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Interpace Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Interpace Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDXG's stock price target?
Not Available

IDXG doesn't have any price targets made by Wall Street professionals.

What is Interpace Biosciences Inc's Revenue forecast?
Projected CAGR
-1%

For the last 13 years the compound annual growth rate for Interpace Biosciences Inc's revenue is -9%. The projected CAGR for the next 3 years is -1%.

Back to Top